On Wednesday, Shares of Ohr Pharmaceutical, Inc. (NASDAQ:OHRP), surged 26.61% to $4.14.
OHR Pharmaceutical, declared positive final results from a Phase II investigator sponsored clinical trial of OHR-102 (0.2% Squalamine lactate ophthalmic solution) in patients with macular edema secondary to branch (BRVO) and central retinal vein occlusion (CRVO). The results demonstrated that, following an initial 10 week combination therapy treatment period, patients who continued to receive a combination of topical OHR-102 BID plus Lucentis(R) achieved greater visual acuity gains than the control group who received Lucentis alone. At week 38, the mean gain in visual acuity from baseline for patients randomized (at week 10) to treatment with OHR-102 + Lucentis PRN was +27.8 letters contrast with +23.3 for patients randomized to treatment with Lucentis plus PRN alone (control group), a clinically meaningful difference of +4.5 letters. The data were presented by John Wroblewski, MD, a retina specialist at Cumberland Valley Retina Consultants on Saturday, July 11 at the 2015 Annual Meeting of the American Society of Retina Specialists (ASRS) in Vienna, Austria.
“These very promising final results demonstrate a clinically meaningful treatment effect of OHR-102 combination therapy for the treatment of macular edema secondary to retinal vein occlusion,” said John Wroblewski, MD, principal investigator of this Phase II study. “The 38 week data confirm a positive and meaningful effect on both visual acuity and macular edema. Importantly, continued treatment with OHR-102 combination therapy for the full 38 weeks of the study resulted in further improvements in visual gains over those patients that only received combination therapy for the first 10 weeks of the study.”
OHR Pharmaceutical, Inc., a pharmaceutical company, focuses on the development of novel therapeutics and delivery technologies for the treatment of ocular disease. Its lead clinical program is OHR-102 eye drops, a novel therapeutic product, which could provide a non-invasive therapy to improve vision outcomes.
Shares of Santander Consumer USA Holdings Inc. (NYSE:SC), inclined 3.59% to $24.84, during its last trading session.
Santander Consumer, declared the appointment of Blythe Masters as non-executive Chairman of the Board of Directors of SCUSA.
Ms. Masters, Chief Executive Officer of Digital Asset Holdings, succeeds Stephen Ferriss, who served as Interim Chairman since July 3, 2015, and remains on the Board. Preceding to leading Digital Asset Holdings, Ms. Masters held senior executive roles at J.P. Morgan Chase & Co., where she served as the head of its global commodities business from 2007 to 2014, as the head of Corporate & Investment Bank Regulatory Affairs from 2012 to 2014, and as Chief Financial Officer of J.P. Morgan’s investment bank from 2004 to 2007. She also has broad experience leading industry associations and non-profit boards.
T. Timothy Ryan, Chairman of the Board of Directors of Santander Holdings USA, Inc., SCUSA’s parent company, said, “Ms. Masters’ global financial experience and leadership in U.S. banking aligns well with our broad development strategy and objectives for Santander’s business in the U.S.”
Santander Consumer USA Holdings Inc., a specialized consumer finance company, provides vehicle finance and unsecured consumer lending products in the United States.
Finally, Ruckus Wireless, Inc. (NYSE:RKUS), ended its last trade with -3.21% loss, and closed at $10.24.
Ruckus Wireless, declared the introduction of its new Ruckus ZoneFlex™ P300 bridge system, the industry’s first long-range, Gigabit-class, outdoor Smart WiFi bridging system. By combining custom integrated directional technology with the new 802.11ac standard, the ZoneFlex™ P300 bridge system delivers blazingly fast broadband connectivity between locations miles away. With its internal antennas, it offers hundreds of megabits of performance at line of sight distances up to 8 kilometers, and over 20 kilometers with external antennas.
Featuring one of the industry’s most compact and lightest form factors, the ZoneFlex P300 bridge system supports RF capacity up to 867 Mbps. It is an ideal solution to easily extend broadband services, backhaul small cell traffic, or offer high-speed broadband connectivity to locations where fixed lines are limited or simply cost-prohibitive. Schools, hotels, warehouses and other outdoor environments can leverage the ZoneFlex P300 bridge system to save tens of thousands of dollars in annual broadband costs.
Ruckus Wireless, Inc. provides carrier-class Wi-Fi solutions to service providers and enterprises worldwide. It provides gateways, controllers, and access points with related software and services.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
